Table 3.
Univariate and Multivariate analyses in patients (n=66) with Allo-HSCT
| EFS | OS | |||
|---|---|---|---|---|
| HR (95%CI) | P-value | HR (95%CI) | P-value | |
| Univariate analysis | ||||
| RhoBTB3 (High vs Low) | 1.200 (0.701-2.055) | 0.506 | 1.036 (0.552-1.946) | 0.912 |
| age (≥60 vs <60) | 0.845 (0.459-1.556) | 0.588 | 1.195 (0.579-2.468) | 0.629 |
| Gender (Male vs Female) | 0.954 (0.550-1.657) | 0.869 | 0.805 (0.427-1.516) | 0.502 |
| WBC (≥100 vs <100×109) | 1.537 (0.602-3.924) | 0.369 | 2.212 (0.756-6.470) | 0.147 |
| RUNX1 mutation (Yes vs No) | 0.762 (0.325-1.787) | 0.532 | 1.256 (0.485-3.249) | 0.639 |
| TP53 mutation (Yes vs No) | 1.650 (0.509-5.346) | 0.404 | 4.559 (1.319-15.755) | 0.016 |
| ASXL1 mutation (Yes vs No) | 0.679 (0.164-2.803) | 0.593 | 0.518 (0.071-3.789) | 0.517 |
| NPM1 mutation (Yes vs No) | 0.863 (0.475-1.567) | 0.628 | 0.904 (0.450-1.816) | 0.776 |
| FLT3-ITD mutation (Yes vs No) | 1.934 (1.041-3.591) | 0.037 | 2.029 (0.969-4.247) | 0.061 |
| biCEBPA mutation (Yes vs No) | 0.617 (0.150-2.546) | 0.504 | 0.712 (0.169-2.989) | 0.642 |
| Multivariate analysis | ||||
| TP53 mutation (Yes vs No) | - | - | 5.732 (1.611-20.398) | 0.007 |
| FLT3-ITD mutation (Yes vs No) | 1.934 (1.041-3.591) | 0.037 | 2.288 (1.076-4.866) | 0.031 |